Teladoc Health, Inc. - 8-K Filing

Teladoc Health reports Q3 2026 revenue of $605.1 million, down 3% YoY, with adjusted EBITDA increasing 14% to $79.4 million. (Items: 2.02 Results of Operations and Financial Condition, 9.01 hereto) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or)

SEC EDGAR · October 28, 2026, 20:06 UTC

Tickers: $TDOC

Read the full article at SEC EDGAR

Part of the story Odyssey Health, Inc. - 10-K Filing (4 articles)